Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DKP21102_B Add-on in Mixed Dyslipidemia
NCT05809687Phase 3Withdrawn
- Sponsor
- Kwang Dong Pharmaceutical Co., Ltd.
- Start
- Jan 2025
- Primary completion
- Dec 2026
01
Overview
A Phase 3 trial of DKP21102_B in mixed dyslipidemia, sponsored by Kwang Dong Pharmaceutical Co., Ltd.. Planned start Jan 2025; status: withdrawn.
02
Drugs
DKP21102_B
03
Conditions
mixed dyslipidemia
Beyond the preview
Go deeper on NCT05809687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05809687.